<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Fri, 21 Aug 2026 14:32:37 -0400--><rss version="2.0">
    <channel>
        <title>Immunocore Holdings plc (IMCR) SEC Filings</title>
        <link>https://www.immunocore.com/investors/financials-filings/sec-filings/rss</link>
        <description>Immunocore Holdings plc (IMCR) - SEC Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_b541aae032f58bf8fdbdeabb137fc49f/immunocore/files/theme/images/logo-sm.png</url>
                <title>Immunocore Holdings plc Logo</title>
                <link>/investors</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]></title>
                <description><![CDATA[SCHEDULE 13G/A]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0000902664-26-003501/0000902664-26-003501.pdf</link>
                <pubDate>Fri, 14 Aug 26 16:16:40 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0000902664-26-003501/0000902664-26-003501.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]></title>
                <description><![CDATA[2 Related Documents: SCHEDULE 13G/A, EX-99]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0000902219-26-000298/0000902219-26-000298.pdf</link>
                <pubDate>Thu, 13 Aug 26 16:19:12 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0000902219-26-000298/0000902219-26-000298.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]></title>
                <description><![CDATA[2 Related Documents: SCHEDULE 13G/A, EX-99]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0000315066-26-002034/0000315066-26-002034.pdf</link>
                <pubDate>Thu, 06 Aug 26 10:29:23 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0000315066-26-002034/0000315066-26-002034.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[4 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001671927-26-000022/0001671927-26-000022.pdf</link>
                <pubDate>Thu, 06 Aug 26 07:06:08 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001671927-26-000022/0001671927-26-000022.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[2 Related Documents: 8-K, EX-99.1]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001671927-26-000020/0001671927-26-000020.pdf</link>
                <pubDate>Thu, 06 Aug 26 07:03:19 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001671927-26-000020/0001671927-26-000020.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001919343-26-000002/0001919343-26-000002.pdf</link>
                <pubDate>Thu, 28 May 26 19:55:47 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001919343-26-000002/0001919343-26-000002.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001508596-26-000002/0001508596-26-000002.pdf</link>
                <pubDate>Thu, 28 May 26 19:55:43 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001508596-26-000002/0001508596-26-000002.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001969518-26-000002/0001969518-26-000002.pdf</link>
                <pubDate>Thu, 28 May 26 19:55:40 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001969518-26-000002/0001969518-26-000002.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001969522-26-000002/0001969522-26-000002.pdf</link>
                <pubDate>Thu, 28 May 26 19:55:36 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001969522-26-000002/0001969522-26-000002.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001969520-26-000002/0001969520-26-000002.pdf</link>
                <pubDate>Thu, 28 May 26 19:55:32 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001969520-26-000002/0001969520-26-000002.pdf</guid>
                                                                            </item>
            </channel>
</rss>